"Item Id","Item URI","Dublin Core:Title","Dublin Core:Subject","Dublin Core:Description","Dublin Core:Creator","Dublin Core:Source","Dublin Core:Publisher","Dublin Core:Date","Dublin Core:Contributor","Dublin Core:Rights","Dublin Core:Relation","Dublin Core:Format","Dublin Core:Language","Dublin Core:Type","Dublin Core:Identifier","Dublin Core:Coverage","Item Type Metadata:Bibliography","Item Type Metadata:Biographical Text","Item Type Metadata:Occupation","Item Type Metadata:Death Date","Item Type Metadata:Birthplace","Item Type Metadata:Text","Item Type Metadata:Player","Item Type Metadata:Access","Item Type Metadata:Alternate URL","Item Type Metadata:Citation","Item Type Metadata:Accessibility","Item Type Metadata:Abstract","Item Type Metadata:Read Online","Item Type Metadata:Additional Exercise","Item Type Metadata:Email Body","Item Type Metadata:Interviewer","Item Type Metadata:Interviewee","Item Type Metadata:Location","Item Type Metadata:Transcription","Item Type Metadata:Local URL","Item Type Metadata:Original Format","Item Type Metadata:Physical Dimensions","Item Type Metadata:Duration","Item Type Metadata:Compression","Item Type Metadata:Producer","Item Type Metadata:Director","Item Type Metadata:Bit Rate/Frequency","Item Type Metadata:Time Summary","Item Type Metadata:Birth Date","Item Type Metadata:Subject Line","Item Type Metadata:From","Item Type Metadata:To","Item Type Metadata:CC","Item Type Metadata:BCC","Item Type Metadata:Number of Attachments","Item Type Metadata:Standards","Item Type Metadata:Objectives","Item Type Metadata:Materials","Item Type Metadata:Lesson Plan Text","Item Type Metadata:URL","Item Type Metadata:Event Type","Item Type Metadata:Participants","PDF Text:Text",tags,file,itemType,collection,public,featured 1681,https://repository.netecweb.org/items/show/1681,"Contributions of the Regional Emerging Special Pathogen Treatment Centers to the US COVID-19 Pandemic Response","Emergency Management","The National Emerging Special Pathogens Training and Education Center (NETEC) was established in 2015 to improve the capabilities of healthcare facilities to provide safe and effective care to patients with Ebola and other special pathogens in the United States.","Jonathan D Grein, Jennifer A Garland, Christa Arguinchona, Maria G Frank, Brian T Garibaldi, Amanda Grindle, Angela Hewlett, Susan Kline, Corri B Levine, Aneesh Mehta, Vikramjit Mukherjee, Lauren M Sauer, Eileen F Searle, Sharon Vanairsdale, Angela Vasa ",,,2022-05-31,,,,,,Publication,,2023-07-20,,,,,,,,,,"Grein, J. D., J. A. Garland, C. Arguinchona, M. G. Frank, B. T. Garibaldi, A. Grindle, A. Hewlett, S. Kline, C. B. Levine, A. Mehta, V. Mukherjee, L. M. Sauer, E. F. Searle, S. Vanairsdale, and A. Vasa. 2022. ""Contributions of the Regional Emerging Special Pathogen Treatment Centers to the US COVID-19 Pandemic Response."" Health Secur 20 (S1):S4-s12. doi: 10.1089/hs.2021.0188. ","Open Access on journal site","The National Emerging Special Pathogens Training and Education Center (NETEC) was established in 2015 to improve the capabilities of healthcare facilities to provide safe and effective care to patients with Ebola and other special pathogens in the United States. Through NETEC, a collaborative network of 10 Regional Emerging Special Pathogen Treatment Centers (RESPTCs) undertook readiness activities that included potential respiratory pathogens. These preparations, which took place before the COVID-19 pandemic, established a foundation of readiness that enabled RESPTCs to play a pivotal role in the US COVID-19 pandemic response. As initial COVID-19 cases were detected in the United States, RESPTCs provided essential isolation capacity, supplies, and subject matter expertise that allowed for additional time for healthcare systems to prepare. Through the Special Pathogen Research Network, RESPTCs rapidly enrolled patients into early clinical trials. During periods of high community transmission, RESPTCs provided educational, clinical, and logistical support to a wide range of healthcare and nonhealthcare settings. In this article, we describe how NETEC and the RESPTC network leveraged this foundation of special pathogen readiness to strengthen the national healthcare system's response to the COVID-19 pandemic. NETEC and the RESPTC network have proven to be an effective model that can support the national response to future emerging special pathogens.",https://www.liebertpub.com/doi/10.1089/hs.2021.0188,,,,,,,,,,,,,,,,,,,,,,,,,,,https://pubmed.ncbi.nlm.nih.gov/35483049/,,,,"Emergency Management,NETEC,Pandemic,R-Res&Pub,Research,Special Pathogens,Treatment Facility",,Publication,Discover,1,0 1553,https://repository.netecweb.org/items/show/1553,"Interim Guidance for Preparing Ebola Treatment Centers","Physical Infrastructure","
Who this is for: State and local health departments and acute care hospitals designated as Ebola treatment centers.
What this is for: Guidance to assist state and local health departments and acute care hospitals as they develop preparedness plans to serve as Ebola treatment centers.
How this relates to other guidance documents/purpose: This guidance is intended to inform efforts by state and local health departments and healthcare facilities to prepare Ebola treatment centers, and includes a summary of the capability elements needed for those hospitals. Context for this guidance document is provided in CDC’s Interim Guidance for U.S. Hospital Preparedness for Patients Under Investigation (PUIs) or Patients with Confirmed Ebola Virus Disease: A Framework for a Tiered Approach. In addition, this guidance complements two other specific CDC guidance documents: Interim Guidance for Preparing Ebola Assessment Hospitals and Interim Guidance for Preparing Frontline Healthcare Facilities for Patients Under Investigation (PUIs) for Ebola Virus Disease.
In response to the 2014-2016 West Africa Ebola virus disease (EVD) epidemic, the Centers for Disease Control and Prevention (CDC) designated 56 US hospitals as Ebola treatment centers (ETCs) with high-level isolation capabilities. We aimed to determine ongoing sustainability of ETCs and identify how ETC capabilities have impacted hospital, local, and regional COVID-19 readiness and response.
Design:An electronic survey included both qualitative and quantitative questions and was structured into two sections: operational sustainability and role in the COVID-19 response.
Setting and Participants:The survey was distributed to site representatives from the 56 originally designated ETCs; 37 (66%) responded.
Methods:Data were coded and analyzed using descriptive statistics.
Results:Of the 37 responding ETCs, 33 (89%) reported they were still operating while 4 had decommissioned. ETCs that maintain high-level isolation capabilities incurred a mean of $234,367 in expenses per year. All but one ETC reported that existing capabilities (e.g., trained staff, infrastructure) before COVID-19 positively affected their hospital, local, and regional COVID-19 readiness and response (e.g., ETCs trained staff, donated supplies, and shared developed protocols).
Conclusions:Existing high-level isolation capabilities and expertise developed following the 2014-2016 EVD epidemic were leveraged by ETCs to assist hospital-wide readiness for COVID-19 and support response for other local and regional hospitals However, ETCs face continued challenges in sustaining those capabilities for high-consequence infectious diseases.
",https://www.cambridge.org/core/journals/infection-control-and-hospital-epidemiology/article/abs/utility-and-sustainability-of-us-ebola-treatment-centers-during-the-covid19-pandemic/C7BAFF7DCF5EAD49D67C37FCE04835BC,,,,,,,,,,,,,,,,,,,,,,,,,,,https://pubmed.ncbi.nlm.nih.gov/35189995/,,,,"2019-nCoV,COVID-19,Ebola,Isolation/Biocontainment,NETEC,Pandemic,R-Res&Pub,Research,Treatment and Care,Treatment Facility",,Publication,Discover,1,0 776,https://repository.netecweb.org/items/show/776,"Update on Ebola Treatment Center Costs and Sustainability, United States, 2019","Physical Infrastructure","We surveyed 56 Ebola treatment centers (ETCs) in the United States and identified costs incurred since 2014 ($1.76 million/ETC) and sustainability strategies.","Herstein, Jocelyn J., Aurora B. Le, Lily A. McNulty, Sean A. Buehler, Paul D. Biddinger, Angela L. Hewlett, John J. Lowe, and Shawn G. Gibbs.",,,2020-05-17,"2023-08-31 by Shawn Gibbs - PhysInfr General Review - COI Gibbs co-author",,,,,Publication,,2026-08-31,,,,,,,,,,"Herstein, Jocelyn J., Aurora B. Le, Lily A. McNulty, Sean A. Buehler, Paul D. Biddinger, Angela L. Hewlett, John J. Lowe, and Shawn G. Gibbs. 2020. ""Update on Ebola Treatment Center Costs and Sustainability, United States, 2019."" Emerging infectious diseases 26 (5):10.3201/eid2605.191245. ","Free online","We surveyed 56 Ebola treatment centers (ETCs) in the United States and identified costs incurred since 2014 ($1.76 million/ETC) and sustainability strategies. ETCs reported heavy reliance on federal funding. It is uncertain if, or for how long, ETCs can maintain capabilities should federal funding expire in 2020.
Ebola; Ebola treatment centers; Ebola virus disease; Ebolavirus; United States; communicable diseases; costs; emerging; hospitals; isolation; sustainability; viruses; zoonoses